Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$176.6K
6 trades · 3 insiders
Net · 90d
$-176.6K
Insiders on file
9
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Woo Ian Ying | Director | 2 | $0 | $0 | 2026-10-15 |
| Dennis Phillip Andrew | Chief Medical Officer | 9 | $0 | $17.3K | 2026-09-18 |
| Cao Sean Wuxiong | See Remarks | 13 | $0 | $202.4K | 2026-09-09 |
| Xu Cong Claire | SVP, Clinical Development | 12 | $0 | $22.9K | 2026-08-31 |
| Lenz Robert A. | Director | 4 | $0 | $0 | 2026-08-22 |
| Hagler Mark Arnold | See Remarks | 2 | $577.3K | $0 | 2026-07-08 |
| Lin Liwei Lorraine | General Counsel | 1 | $0 | $0 | 2026-07-08 |
| Gupta Srishti | Chief Executive Officer | 1 | $0 | $0 | 2026-07-06 |
| Fu Wei | Director | 4 | $0 | $0 | 2026-06-29 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Woo Ian Ying | Director | M Exercise deriv | 2026-10-15 | 2026-10-19 | 5,770 | — | $0 | 11,540 | SEC↗ |
| Woo Ian Ying | Director | M Exercise | 2026-10-15 | 2026-10-19 | 13,271 | — | — | 13,271 | SEC↗ |
| Dennis Phillip Andrew | Chief Medical Officer | S Sale | 2026-09-18 | 2026-09-21 | 8,209 | $0.71 | $5.8K | 173,427 | SEC↗ |
| Dennis Phillip Andrew | Chief Medical Officer | S Sale | 2026-09-18 | 2026-09-21 | 8,209 | $0.71 | $5.8K | 173,427 | SEC↗ |
| Dennis Phillip Andrew | Chief Medical Officer | M Exercise deriv | 2026-09-17 | 2026-09-21 | 10,302 | — | $0 | 72,120 | SEC↗ |
| Dennis Phillip Andrew | Chief Medical Officer | M Exercise | 2026-09-17 | 2026-09-21 | 23,695 | — | $0 | 181,636 | SEC↗ |
| Dennis Phillip Andrew | Chief Medical Officer | M Exercise deriv | 2026-09-17 | 2026-09-21 | 10,302 | — | $0 | 72,120 | SEC↗ |
| Dennis Phillip Andrew | Chief Medical Officer | M Exercise | 2026-09-17 | 2026-09-21 | 23,695 | — | — | 181,636 | SEC↗ |
| Cao Sean Wuxiong | Chief Bus. Development Offic | S Sale | 2026-09-09 | 2026-09-11 | 107,978 | $0.74 | $79.9K | 266,467 | SEC↗ |
| Cao Sean Wuxiong | Chief Bus. Development Offic | S Sale | 2026-09-09 | 2026-09-11 | 107,978 | $0.74 | $79.9K | 266,467 | SEC↗ |
| Cao Sean Wuxiong | Chief Bus. Development Offic | M Exercise deriv | 2026-09-03 | 2026-09-08 | 102,233 | — | $0 | 306,700 | SEC↗ |
| Cao Sean Wuxiong | Chief Bus. Development Offic | M Exercise deriv | 2026-09-03 | 2026-09-08 | 45,320 | — | $0 | 135,960 | SEC↗ |
| Cao Sean Wuxiong | Chief Bus. Development Offic | M Exercise | 2026-09-03 | 2026-09-08 | 235,136 | — | $0 | 270,209 | SEC↗ |
| Cao Sean Wuxiong | Chief Bus. Development Offic | M Exercise | 2026-09-03 | 2026-09-08 | 104,236 | — | $0 | 374,445 | SEC↗ |
| Cao Sean Wuxiong | Chief Bus. Development Offic | M Exercise deriv | 2026-09-03 | 2026-09-08 | 45,320 | — | $0 | 135,960 | SEC↗ |
| Cao Sean Wuxiong | Chief Bus. Development Offic | M Exercise deriv | 2026-09-03 | 2026-09-08 | 102,233 | — | $0 | 306,700 | SEC↗ |
| Cao Sean Wuxiong | Chief Bus. Development Offic | M Exercise | 2026-09-03 | 2026-09-08 | 104,236 | — | — | 374,445 | SEC↗ |
| Cao Sean Wuxiong | Chief Bus. Development Offic | M Exercise | 2026-09-03 | 2026-09-08 | 235,136 | — | — | 270,209 | SEC↗ |
| Xu Cong Claire | EVP, Clinical Development | S Sale | 2026-08-31 | 2026-09-01 | 3,282 | $0.79 | $2.6K | 304,201 | SEC↗ |
| Xu Cong Claire | EVP, Clinical Development | S Sale | 2026-08-31 | 2026-09-01 | 3,282 | $0.79 | $2.6K | 304,201 | SEC↗ |
| Xu Cong Claire | EVP, Clinical Development | M Exercise deriv | 2026-08-30 | 2026-09-01 | 4,079 | — | $0 | 28,558 | SEC↗ |
| Xu Cong Claire | EVP, Clinical Development | M Exercise | 2026-08-30 | 2026-09-01 | 9,382 | — | $0 | 307,483 | SEC↗ |
| Xu Cong Claire | EVP, Clinical Development | M Exercise deriv | 2026-08-30 | 2026-09-01 | 4,079 | — | $0 | 28,558 | SEC↗ |
| Xu Cong Claire | EVP, Clinical Development | M Exercise | 2026-08-30 | 2026-09-01 | 9,382 | — | — | 307,483 | SEC↗ |
| Lenz Robert A. | Director | M Exercise deriv | 2026-08-22 | 2026-08-25 | 7,486 | — | $0 | 14,974 | SEC↗ |
| Lenz Robert A. | Director | M Exercise | 2026-08-22 | 2026-08-25 | 17,218 | — | $0 | 17,218 | SEC↗ |
| Lenz Robert A. | Director | M Exercise deriv | 2026-08-22 | 2026-08-25 | 7,486 | — | $0 | 14,974 | SEC↗ |
| Lenz Robert A. | Director | M Exercise | 2026-08-22 | 2026-08-25 | 17,218 | — | — | 17,218 | SEC↗ |
| Hagler Mark Arnold | Chief Commercial Officer | A Award deriv | 2026-07-08 | 2026-07-10 | 949,050 | — | $0 | 949,050 | SEC↗ |
| Lin Liwei Lorraine | General Counsel | A Award deriv | 2026-07-08 | 2026-07-10 | 254,780 | — | $0 | 254,780 | SEC↗ |
| Gupta Srishti | Chief Executive Officer | A Award deriv | 2026-07-06 | 2026-07-08 | 3,000,000 | — | $0 | 3,000,000 | SEC↗ |
| Xu Cong Claire | SVP, Clinical Development | S Sale | 2026-07-06 | 2026-07-07 | 4,485 | $0.89 | $4.0K | 298,101 | SEC↗ |
| Xu Cong Claire | SVP, Clinical Development | M Exercise deriv | 2026-07-04 | 2026-07-07 | 5,405 | — | $0 | 0 | SEC↗ |
| Xu Cong Claire | SVP, Clinical Development | M Exercise | 2026-07-04 | 2026-07-07 | 12,432 | — | $0 | 302,586 | SEC↗ |
| Fu Wei | Director | A Award deriv | 2026-06-29 | 2026-06-30 | 725,140 | — | $0 | 725,140 | SEC↗ |
| Fu Wei | Director | A Award deriv | 2026-06-29 | 2026-06-30 | 1,010,100 | — | $0 | 1,010,100 | SEC↗ |
| Fu Wei | Director | A Award deriv | 2026-06-29 | 2026-06-30 | 1,087,720 | — | $0 | 1,087,720 | SEC↗ |
| Fu Wei | Director | A Award deriv | 2026-06-29 | 2026-06-30 | 1,087,720 | — | $0 | 1,087,720 | SEC↗ |
| Cao Sean Wuxiong | Chief Bus. Development Offic | A Award deriv | 2026-06-22 | 2026-06-24 | 181,280 | — | $0 | 181,280 | SEC↗ |
| Cao Sean Wuxiong | Chief Bus. Development Offic | A Award deriv | 2026-06-22 | 2026-06-24 | 181,290 | — | $0 | 181,290 | SEC↗ |
| Dennis Phillip Andrew | Chief Medical Officer | S Sale | 2026-06-18 | 2026-06-22 | 8,494 | $0.66 | $5.6K | 157,941 | SEC↗ |
| Dennis Phillip Andrew | Chief Medical Officer | M Exercise deriv | 2026-06-17 | 2026-06-22 | 10,302 | — | $0 | 82,422 | SEC↗ |
| Dennis Phillip Andrew | Chief Medical Officer | M Exercise | 2026-06-17 | 2026-06-22 | 23,695 | — | $0 | 166,435 | SEC↗ |
| Xu Cong Claire | SVP, Clinical Development | S Sale | 2026-06-01 | 2026-06-02 | 3,494 | $3.94 | $13.8K | 290,154 | SEC↗ |
| Xu Cong Claire | SVP, Clinical Development | M Exercise deriv | 2026-05-30 | 2026-06-02 | 4,079 | — | $0 | 32,637 | SEC↗ |
| Xu Cong Claire | SVP, Clinical Development | M Exercise | 2026-05-30 | 2026-06-02 | 9,382 | — | $0 | 293,648 | SEC↗ |
| Cao Sean Wuxiong | See Remarks | S Sale | 2026-05-14 | 2026-05-18 | 21,399 | $1.99 | $42.6K | 35,073 | SEC↗ |
| Hagler Mark Arnold | See Remarks | P Buy | 2026-04-24 | 2026-04-28 | 230,000 | $2.51 | $577.3K | 230,000 | SEC↗ |